Doctor profile · Federal record
Dr. Dana Thompson, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Nashville, TN
- NPI 1306862669
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
250 25Th Ave N, Ste 100
Nashville, TN 372031632
(615) 320-5090
fax (615) 320-1225 - Mailing address
-
Po Box 440100
Nashville, TN 372440100
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 24, 2012
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Tennessee #22044
- Medicaid (2)
- KY #64922834 · TN #3076802
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306862669. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
209,032
Distinct HCPCS
10
Medicare allowed
$2,770,920
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 64,500 | 49 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 52,100 | 43 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 22,000 | 22 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 16,120 | 15 | $30 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 12,800 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 11,520 | 37 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,608 | 11 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 4,294 | 93 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,289 | 458 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 2,040 | 458 | $8 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 1,132. This provider delivers 185× the peer median.Open Payments
Industry payments received
All-time total
$9,430
Transactions
26
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 14 | $9,145.30 | |
| AstraZeneca Pharmaceuticals LP | 2 | $39.84 | |
| Alexion Pharmaceuticals, Inc. | 1 | $34.17 | |
| Rigel Pharmaceuticals, Inc. | 1 | $29.79 | |
| ABBVIE INC. | 1 | $28.03 | |
| Merck Sharp & Dohme LLC | 1 | $25.25 | |
| Celgene Corporation | 1 | $23.60 | |
| Janssen Biotech, Inc. | 1 | $23.52 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.94 | |
| Deciphera Pharmaceuticals Inc. | 1 | $21.10 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $20.85 | |
| PFIZER INC. | 1 | $15.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
847
Patients
175
Total drug cost
$4,414,871
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 102 | 24 | $3,448 |
| Acyclovir | Generic | 98 | 17 | $1,624 |
| Anastrozole | Generic | 90 | 23 | $1,439 |
| Revlimid (Lenalidomide) | Brand | 90 | 15 | $1,724,117 |
| Dexamethasone | Generic | 69 | 16 | $1,566 |
| Prochlorperazine Maleate | Generic | 50 | 24 | $1,231 |
| Pantoprazole Sodium | Generic | 48 | 0 | $463 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 46 | 0 | $840,147 |
| Xtandi (Enzalutamide) | Brand | 42 | 0 | $606,881 |
| Calquence (Acalabrutinib Maleate) | Brand | 40 | 0 | $616,829 |
Hospital affiliations
Frequently asked questions
What is Dr. Dana Thompson's medical specialty?
Dr. Dana Thompson practices Medical Oncology Physician in Nashville, TN.
Where does Dr. Dana Thompson practice?
Dr. Dana Thompson practices at 250 25Th Ave N, Nashville, TN 372031632. Office phone: 6153205090.
What is Dr. Dana Thompson's NPI?
Dr. Dana Thompson's National Provider Identifier (NPI) is 1306862669, issued by NPPES.
Does Dr. Dana Thompson accept Medicare assignment?
Yes. Dr. Dana Thompson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dana Thompson commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.